Abteilungspublikationen 2010
Feasibility and radiation dose of high-pitch acquisition protocols in patients undergoing dual-source cardiac CT.
Sommer WH, Albrecht E, Bamberg F, Schenzle JC, Johnson TR, Neumaier K, Reiser MF, Nikolaou K.AJR Am J Roentgenol. 2010 Dec;195(6):1306-12. [PubMed - indexed for MEDLINE]
The Akt-inhibitor Erufosine induces apoptotic cell death in prostate cancer cells and increases the short term effects of ionizing radiation.
Rudner J, Ruiner CE, Handrick R, Eibl HJ, Belka C, Jendrossek V.
Radiat Oncol. 2010 Nov 16;5:108.
Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells.
Zoppoli G, Cea M, Soncini D, Fruscione F, Rudner J, Moran E, Caffa I, Bedognetti D, Motta G, Ghio R, Ferrando F, Ballestrero A, Parodi S, Belka C, Patrone F, Bruzzone S, Nencioni A.
Exp Hematol. 2010 Nov;38(11):979-88.
Irradiation and Bevacizumab in High-Grade Glioma Retreatment Settings.
Niyazi M, Ganswindt U, Schwarz SB, Kreth FW, Tonn JC, Geisler J, la Fougère C, Ertl L, Linn J, Siefert A, Belka C.
Int J Radiat Oncol Biol Phys. 2010 Oct 27. [Epub ahead of print]
Special Report: Workshop on 4D-treatment planning in actively scanned particle therapy - Recommendations, technical challenges and future research directions
Knopf A, Bert C, Heath E, Nill S, Kraus K, Richter D, Hug E, Pedroni E, Safai S, Albertini F, Zenklusen S, Boye D, Söhn M, Soukup M, Sobotta B, Lomax A
Med Phys. 2010 Sept;37(9):4608-14
Predominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomide.
Thon N, Eigenbrod S, Grasbon-Frodl EM, Lutz J, Kreth S, Popperl G, Belka C, Kretzschmar HA, Tonn JC, Kreth FW.
J Neurol Neurosurg Psychiatry. 2010 Sep 22.
Distribution of Prostate Sentinel Nodes: A SPECT-Derived Anatomic Atlas.
Ganswindt U, Schilling D, Müller AC, Bares R, Bartenstein P, Belka C.
Int J Radiat Oncol Biol Phys. 2010 Aug 24.
Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer.
Wolf M, Zehentmayr F, Niyazi M, Ganswindt U, Haimerl W, Schmidt M, Hölzel D, Belka C.
Strahlenther Onkol. 2010 Jul;186(7):374-81.
Definitive radiotherapy and single-agent radiosensitizing ifosfamide in patients with localized, irresectable soft tissue sarcoma: a retrospective analysis.
Eckert F, Matuschek C, Mueller AC, Weinmann M, Hartmann JT, Belka C, Budach W.
Radiat Oncol. 2010 Jun 16;5:55.PMID: 20553599
Dual energy CT of the chest: how about the dose?
Schenzle JC, Sommer WH, Neumaier K, Michalski G, Lechel U, Nikolaou K, Becker CR, Reiser MF, Johnson TR.
Invest Radiol. 2010 Jun;45(6):347-53.
Reirradiation with alternating docetaxel-based chemotherapy for recurrent head and neck squamous cell carcinoma: update of a single-center prospective phase II protocol.
Berger B, Belka C, Weinmann M, Bamberg M, Budach W, Hehr T.
Strahlenther Onkol. 2010 May;186(5):255-61. Epub 2010 Apr 26.
Intensity-modulated radiotherapy for a rendu-osler-weber disease patient with recurrent severe epistaxis: a case report.
Niyazi M, Caversaccio MD, Dubach P, Geretschläger A, Arnold A, Belka C, Aebersold DM, Blumstein NM.
Case Report Med. 2010;2010:321835. Epub 2010 Mar 28.
Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma.
Gillissen B, Wendt J, Richter A, Richter A, Müer A, Overkamp T, Gebhardt N, Preissner R, Belka C, Dörken B, Daniel PT.
J Cell Biol. 2010 Mar 22;188(6):851-62.
Choline PET based dose-painting in prostate cancer--modelling of dose effects.
Niyazi M, Bartenstein P, Belka C, Ganswindt U.
Radiat Oncol. 2010 Mar 18;5:23.
Dihydroartemisinin Induces Apoptosis by a Bak-dependent Intrinsic Pathway.
Handrick R, Ontikatze T, Bauer KD, Freier F, Rübel A, Dürig J, Belka C, Jendrossek V.
Mol Cancer Ther. 2010 Jul 27. [Epub ahead of print]PMID: 20663933 [PubMed - as supplied by publisher]
Definitive radiochemotherapy for cancer of the esophagus
F. Zehentmayr, M. Wolf, W. Budach und C. Belka
Der Onkologe, Volume 16, Number 5
Radiation therapy for solitary plasmacytoma or multiple myeloma
S. Corradini, C. Belka und L. Plasswilm
Der Onkologe, Volume 16, Number 3
Aurora kinase inhibitor ZM447439 induces apoptosis via mitochondrial pathways.
Li M, Jung A, Ganswindt U, Marini P, Friedl A, Daniel PT, Lauber K, Jendrossek V, Belka C.
Biochem Pharmacol. 2010 Jan 15;79(2):122-9. Epub 2009 Aug 15.
Differential effects of anti-apoptotic Bcl-2 family members Mcl-1, Bcl-2, and Bcl-xL on celecoxib-induced apoptosis.
Rudner J, Elsaesser SJ, Müller AC, Belka C, Jendrossek V.
Biochem Pharmacol. 2010 Jan 1;79(1):10-20. Epub 2009 Aug 7.
The place of interstitial brachytherapy and radiosurgery for low-grade gliomas.
Kreth FW, Thon N, Siefert A, Tonn JC.
Adv Tech Stand Neurosurg. 2010;35:183-212.
PMID: 20102115 [PubMed - in process]
